NCT05911594View on ClinicalTrials.gov

IDB Injection Combined With PTNS for Managing Children With OAB Not Responding to Monotherapy

NACompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

February 14, 2022

Primary Completion Date

February 14, 2023

Study Completion Date

February 14, 2023

Conditions
BOTOXPercutaneous Tibial Nerve Stimulation
Interventions
DRUG

Solifenacin group

Patients in this group will receive medical treatment (Solifenacin 5 mg once or twice daily) without any second line of treatment

PROCEDURE

Percutaneous tibial nerve stimulation group

Patients in this group will receive Percutaneous tibial nerve stimulation after failure of medical therapy

DRUG

Intradetrusor BOTOX group

Patients in this group will receive Intradetrusor BOTOX after failure of medical

COMBINATION_PRODUCT

Intradetrusor BOTOX combined with Percutaneous tibial nerve stimulation group

Patients in this group will receive Intradetrusor BOTOX combined with Percutaneous tibial nerve stimulation after failure of medical

Trial Locations (1)

13511

Pediatric Urology departments Benha University Hospitals, Banhā

All Listed Sponsors
lead

Benha University

OTHER